Abstract:Recently, molecular generation models based on deep learning have attracted significant attention in drug discovery. However, most existing molecular generation models have serious limitations in the context of drug design wherein they do not sufficiently consider the effect of the three-dimensional (3D) structure of the target protein in the generation process. In this study, we developed a new deep learning-based molecular generator, SBMolGen, that integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations. The results of an evaluation using four target proteins (two kinases and two G protein-coupled receptors) showed that the generated molecules had a better binding affinity score (docking score) than the known active compounds, and the generated molecules possessed a broader chemical space distribution. SBMolGen not only generates novel binding active molecules but also presents 3D docking poses with target proteins, which will be useful in subsequent drug design. The code is available at <a class="extLink" href="https://github.com/clinfo/SBMolGen">https://github.com/clinfo/SBMolGen</a>.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00679</a>.Number of generated molecules, example of generated molecules for target EGFR at C = 1.0, example of generated molecules for target AA2AR at C = 1.0, example of generated molecules for target ADRB2 at C = 1.0; distribution of the similarity score of the generated molecules and distribution of the scaffold similarity score of the generated molecules; distribution of the SA scores of the generated molecules; distributions of the QED scores of the generated molecules; plots of IFIE<sub>sum</sub> against experimentally determined Δ<i>G</i> for (A) nine CDK2 inhibitors and (B) generated molecules; distribution of the docking scores of the generated molecules against DDR1; chemical structures of nine CDK2 inhibitors and their properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00679/suppl_file/ci1c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Generating 3D molecules conditional on receptor binding sites with deep generative models

Generating 3D Molecular Structures Conditional on a Receptor Binding Site with Deep Generative Models

Learning a Continuous Representation of 3D Molecular Structures with Deep Generative Models

Advances in Deep Learning-Based 3D Molecular Generative Models

PrefixMol: Target- and Chemistry-aware Molecule Design Via Prefix Embedding

A Unified Conditional Diffusion Framework for Dual Protein Targets Based Bioactive Molecule Generation

In-Pocket 3D Graphs Enhance Ligand-Target Compatibility in Generative Small-Molecule Creation

Equivariant Shape-Conditioned Generation of 3D Molecules for Ligand-Based Drug Design

MOLUCINATE: A Generative Model for Molecules in 3D Space

BindGPT: A Scalable Framework for 3D Molecular Design via Language Modeling and Reinforcement Learning

Generation of 3D molecules in pockets via a language model

Generative Model for Small Molecules with Latent Space RL Fine-Tuning to Protein Targets

A Simple Way to Incorporate Target Structural Information in Molecular Generative Models

Learning to design drug-like molecules in three-dimensional space using deep generative models

Deep Generative Design with 3D Pharmacophoric Constraints

Seq2Mol: Automatic design of de novo molecules conditioned by the target protein sequences through deep neural networks

3D molecular generative framework for interaction-guided drug design

Generate Novel Molecules With Target Properties Using Conditional Generative Models

Fragment-Based Ligand Generation Guided By Geometric Deep Learning On Protein-Ligand Structure

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations